A new study published in the journal of The Lancet Infectious Diseases showed that an efficient substitute for current COVID-19 therapies is ensitrelvir, a once-daily oral SARS-CoV-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback